297 related articles for article (PubMed ID: 3498761)
1. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
Hamilton BL
J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
[TBL] [Abstract][Full Text] [Related]
2. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
Korngold R; Sprent J
J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
[TBL] [Abstract][Full Text] [Related]
3. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
Thiele DL; Charley MR; Calomeni JA; Lipsky PE
J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
[TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.
Parkman R
J Immunol; 1986 May; 136(10):3543-8. PubMed ID: 2871104
[TBL] [Abstract][Full Text] [Related]
5. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
6. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD.
Sprent J; Schaefer M; Korngold R
J Immunol; 1990 Apr; 144(8):2946-54. PubMed ID: 1969878
[TBL] [Abstract][Full Text] [Related]
7. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
Via CS; Sharrow SO; Shearer GM
J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
[TBL] [Abstract][Full Text] [Related]
8. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
9. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
Korngold R
Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of various T cell subtypes on GVHD in a murine model for MHC-matched unrelated donor transplant.
OKunewick JP; Kociban DL; Buffo MJ
Bone Marrow Transplant; 1990 Mar; 5(3):145-52. PubMed ID: 1691938
[TBL] [Abstract][Full Text] [Related]
11. Effect of graft-versus-host disease on anti-tumor immunity.
Schreiber KL; Forman J
J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
[TBL] [Abstract][Full Text] [Related]
12. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens.
Korngold R; Wettstein PJ
J Immunol; 1990 Dec; 145(12):4079-88. PubMed ID: 2258608
[TBL] [Abstract][Full Text] [Related]
13. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
14. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
Korngold R; Leighton C; Mobraaten LE; Berger MA
Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
[TBL] [Abstract][Full Text] [Related]
15. Evidence for two distinct mechanisms in acute fatal graft-versus-host reaction across minor histocompatibility barriers.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1987 May; 15(4):365-72. PubMed ID: 3494625
[TBL] [Abstract][Full Text] [Related]
16. Epidermal lesions of the GVHR: evaluation of the role of different MHC and non MHC loci and of the Ly-2+ and L3T4+ T lymphocytes.
Piguet PF; Janin-Mercier A; Vassalli P; Saurat JH
J Immunol; 1987 Jul; 139(2):406-10. PubMed ID: 2955041
[TBL] [Abstract][Full Text] [Related]
17. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
Hamilton BL; Bevan MJ; Parkman R
J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
[TBL] [Abstract][Full Text] [Related]
18. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
[TBL] [Abstract][Full Text] [Related]
19. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
[TBL] [Abstract][Full Text] [Related]
20. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.
Suzuki Y; Remington JS
J Immunol; 1988 Jun; 140(11):3943-6. PubMed ID: 3259601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
